Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$24.25 – $25.55
93% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2M | $22.6M | $44.7M | $66.4M | $111.9M | $235.2M |
| Cost of revenue | $514.7K | $14.2M | $5.9M | $6.5M | $11.4M | $28.9M |
| Gross profit | $710.0K | $8.4M | $38.8M | $59.9M | $100.6M | $206.4M |
| Gross margin | 58.0% | 37.1% | 86.8% | 90.2% | 89.8% | 87.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.4M | $937.1K | $33.7M | $24.1M | −$888.3K | $88.8M |
| EBITDA | $662.0K | $1.0M | $33.3M | $23.8M | $6.8M | $110.1M |
| Net income | $662.0K | $997.4K | $31.7M | $9.5M | −$24.0M | $36.5M |
| Net margin | 54.1% | 4.4% | 70.9% | 14.3% | -21.4% | 15.5% |
| EPS (diluted) | -0.25 | 0.37 | 0.63 | 0.16 | -0.34 | 0.38 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $260M | $1.00 | $1.00–$1.00 | 1 |
| 2027 | $288M | $1.13 | $1.13–$1.13 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ABLLL.
No tracked institution reports a position in ABLLL as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-11-13 | $0.6172 | 2025-11-14 |
| 2025-08-14 | $0.6172 | 2025-08-15 |
| 2025-05-13 | $0.6172 | 2025-05-15 |
| 2025-02-13 | $0.6172 | 2025-02-14 |
| 2024-11-14 | $0.6172 | 2024-11-15 |
| 2024-08-14 | $0.6172 | 2024-08-15 |
| 2024-05-13 | $0.6172 | 2024-05-15 |
No one on the platform has traded ABLLL yet.
| +0.00% |
| $59M |
| — |
| KCLIKansas City Life Insurance Company | $33.42 | +0.00% | $324M | — |
| PKINPekin Life Insurance Company | $11.75 | +0.00% | $201M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 12.7× sales vs its 16.4× historical median P/S.
Fair value ≈ $32.79 · price $25.46 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.